TrialNCT06445075Phase 2Completed
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Study sponsor: Scholar Rock, Inc.
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2025-03-04Actual
Enrollment · participants102Actual
Source updated2026-01-23Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.